Information
-
Trademark
-
79249944
-
Serial Number
79249944
-
Registration Number
5929291
-
International Classifications
-
Filing Date
September 20, 2018
7 years ago
-
Registration Date
December 10, 2019
6 years ago
-
Transaction Date
December 10, 2024
a year ago
-
Status Date
December 10, 2019
6 years ago
-
Published for Opposition Date
September 24, 2019
6 years ago
-
Location Date
December 10, 2019
6 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
VAGHANI, MAYUR
-
Attorney Docket Number
TM19-0220
Law Office Assigned Location Code
O30
-
Owners
Mark Drawing Code
5
Mark Identification
HYA
Case File Statements
- DM0000: The mark consists of the stylized word "HYA" written vertically.
- GS0051: Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic and endocrine diseases, namely, diabetes, diabetic complication, hyperlipidemia, hyperuricemia, gout, lifestyle related disease, nutritional disorders, impaired glucose tolerance, metabolic syndrome, obesity and lipid disorder, cardiovascular, urological and reproductive diseases, namely, hypertension, hyperglycemia, ischemic heart disease, hyperinsulinemia, arteriosclerosis, myocardial infarction, angina pectoris, aneurysm, chronic kidney disease, renal calculi, kidney disease, pyelonephritis, nephritis, urethritis, cystitis, hypercholesterolemia and high triglyceridemia, respiratory diseases, namely, bronchitis, pulmonary emphysema and lung inflammation, digestive and oral diseases, namely, abnormality of the intestinal flora, abdominal distension, peptic ulcer, intestinal disease, inflammatory disorder, irritable bowel syndrome, gastric ulcer, inflammatory bowel disease, Crohn's disease, diverticulitis, liver cirrhosis, fatty liver, diarrhea, constipation, loose stool disease, hepatic inflammation, non-alcoholic steatohepatitis, viral hepatitis, alcoholic hepatitis, dental disease, periodontal diseases, stomatitis, xerostomia and cyst, immune, inflammatory and allergic diseases, namely, immune related diseases and abnormalities, type I, II, III, IV and V allergy, pollinosis, atopic dermatitis, psoriasis, autoimmune disease and connective tissue disease, bone and articular diseases, namely, rheumatism, osteoporosis and articular inflammation, pathogenic microbial and malignant neoplastic diseases, namely, infection, cancer and malignant tumor, mental and nervous system diseases, namely, mental disorder, dementia, Alzheimer's disease, bipolar disorder, depression, anorexia, insomnia, cerebral apoplexy, cerebral infarction, autism, neuroinflammation, overwork related disease and nerve inflammation related diseases and cancers resulting from chronic inflammation, and sensory system and skin diseases, namely, ophthalmic disease, ocular inflammation, otorhinolaryngology disease and skin inflammation; pharmaceutical preparations in the nature of medicines for dental purposes; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceutical for medicine doses; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages; antiseptic liquid bandages; breast-nursing pads; dental composite, impression and porcelain materials; dental materials, namely, dental porcelain materials, materials for making dental impressions and composite materials for dental and dental technical purposes; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies, namely, human breast milk, powdered milk, isotonic beverages for babies; food for babies; dietary supplements for animals
- GS0161: Paper and cardboard; printed matter, namely, paper signs, books, manuals, curricula, newsletters, information cards and brochures in the field of health
- CC0000: Color is not claimed as a feature of the mark.
- GS0351: Advertising and publicity services
- TR0010: The wording "HYA" has no meaning in a foreign language.
- GS0011: Chemicals, namely, chemical additives for use in the manufacture of food, pharmaceuticals, cosmetics and animal feed; perfluorinated chemical compounds prepared synthetically for use in the manufacture of cosmetics and pharmaceuticals; food preserving chemicals; chemical preparations for preserving foodstuffs; chemical products for the fresh-keeping and preserving of food; chemical products for stabilizing foodstuffs; chemicals for industrial purposes; chemicals for use in the manufacture of a wide variety of goods; glue and adhesives for industrial purposes; plant growth regulating preparations; fertilizers; higher fatty acids for industrial purposes; chemical compositions for developing, printing and enlarging photographs; unprocessed plastics
Case File Event Statements
-
1/24/2019 - 7 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR
-
1/25/2019 - 7 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
1/25/2019 - 7 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
1/25/2019 - 7 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
1/26/2019 - 7 years ago
5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
1/29/2019 - 7 years ago
6 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
2/8/2019 - 7 years ago
7 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
2/8/2019 - 7 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
3/2/2019 - 7 years ago
9 - REFUSAL PROCESSED BY IB
Type: RFNT
-
7/17/2019 - 6 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
7/17/2019 - 6 years ago
11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
7/22/2019 - 6 years ago
12 - ASSIGNED TO LIE
Type: ALIE
-
7/25/2019 - 6 years ago
13 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
7/25/2019 - 6 years ago
14 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
8/19/2019 - 6 years ago
15 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
9/4/2019 - 6 years ago
16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
9/18/2019 - 6 years ago
17 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Type: OP2R
-
9/18/2019 - 6 years ago
18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
9/24/2019 - 6 years ago
19 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
9/24/2019 - 6 years ago
20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
10/5/2019 - 6 years ago
21 - NOTIFICATION PROCESSED BY IB
Type: GPNX
-
12/10/2019 - 6 years ago
22 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
3/10/2020 - 6 years ago
23 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
3/24/2020 - 6 years ago
24 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
3/24/2020 - 6 years ago
25 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
4/10/2020 - 6 years ago
26 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
2/12/2021 - 5 years ago
27 - CHANGE OF OWNER RECEIVED FROM IB
Type: CHLD
-
12/10/2024 - a year ago
28 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Type: REM3